Article

Discussing Cancer Symptom Management With Nurse Darcy Burbage

Author(s):

CURE staff

Cancer survivors often experience physical and psychosocial long-term and late effects after treatment ends.

Cancer survivors often experience physical and psychosocial long-term and late effects after treatment ends. Although most individuals experience some types of side effects during treatment, it is often surprising to survivors that some side effects can linger on after treatment is over, or can appear later on.

Nurses and patients have a lot to learn from each other to help us better understand and manage the effects of cancer treatment.

Please join our guest host Darcy Burbage (@DarcyBurbage on Twitter) as we discuss the challenges of treatment-related changes and share resources and advice.

Darcy is a survivorship nurse navigator and oncology nurse advocate, focused on bringing evidence- based strategies for quality survivorship care to oncology. Darcy guest blogs for Oncology Nursing News and also has written for the Association of Community Cancer Centers. She is a highly regarded nurse leader, currently serving as Chair of the ONS Communities Advisory Panel with the Oncology Nursing Society.

We hope to see you Thursday, July 7th on Twitter at 9 p.m. EST. Don’t forget to include the #CureConnect hashtag in all of your responses! Read more here about the #CureConnect chat and how to participate.

Tweet: I’ll be at the #CureConnect chat July 7 at 9pm EST with @cure_magazine and @oncnursingnews talking symptom management. Join me!

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
CURE spoke with an expert to learn what patients need to know about immunotherapy-induced diabetes.
Minimally Invasive Surgery Transforms Lung Cancer Recovery
Image of man with text.
Image of woman with text.
Unlike most GI cancers, GIST starts in supportive stromal tissue, not surface cells, and is classified as a sarcoma, says Dr. Weijing Sun.
Six-time cancer survivor Staci Kirk urges patients to trust their bodies and speak up to ensure their needs are understood and addressed throughout cancer care.
Clinical trials should be designed to ease travel and financial burdens by using local care, telehealth and remote tools, Kimberly Demirhan explained.
Certain treatments may accelerate aging in survivors, but tailored care and healthy habits can help reduce long-term risks, researchers said.
Image of man with text.
Related Content
Image of man with text.
August 3rd 2025

Revolutionizing CAR T-Cell Therapy to Improve Patient Access

Ryan Scott
Dr. Olalekan O. Oluwole, discusses treating patients from underserved communities with CAR T-cell therapy, as well as highlighted the therapy's evolution.
The Importance of Spotting Endometrial Cancer
August 3rd 2025

The Importance of Spotting Endometrial Cancer

Endometrial cancer is on the rise. Hear survivor Angélica and Eisai Inc.'s Teresa Cronin discuss the Spot Her® initiative, which empowers women to spot early signs. This episode is sponsored by Eisai.
Image of FDA approval.
August 3rd 2025

Breaking Down Every FDA Approval Across Oncology During July 2025

Ryan Scott
Meta: In July of 2025, the U.S. Food and Drug Administration approved various anti-cancer treatments and therapeutic approaches across a range of disease types.
ROS1+ Non-Small Cell Lung Cancer: Progress in Care
August 3rd 2025

ROS1+ Non-Small Cell Lung Cancer: Progress in Care

This episode of the Cancer Horizons podcast features Dr. Jason Porter – a medical oncologist and hematologist at the West Cancer Center and Research Institute and Director of the Lung Cancer Disease research group and is sponsored by Bristol Myers Squibb.
The BMT-CARE app boosted quality of life, as well as lowered depression and PTSD symptoms: © stock.adobe.com.
August 3rd 2025

BMT-CARE App Improves Quality of Life and Mental Health for Caregivers

Spencer Feldman
BMT-CARE app boosted quality of life, lowered depression and PTSD symptoms, and improved coping mechanisms for caregivers of stem cell transplant patients.
Image of man with text.
August 3rd 2025

Understanding Epithelioid Hemangioendothelioma: A Rare Vascular Cancer

Gina Mauro
Dr. Michael Wagner covers the basics of epithelioid hemangioendothelioma, a rare vascular cancer, spanning symptoms, diagnosis, treatment options and more.